SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-13-014731
Filing Date
2013-11-14
Accepted
2013-11-14 09:18:08
Documents
14
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nby20130930_10q.htm 10-Q 1165745
2 EXHIBIT 1.1 ex1-1.htm EX-1 208150
3 EXHIBIT 5.1 ex5-1.htm EX-5 12343
4 EXHIBIT 31.1 ex31-1.htm EX-31 10664
5 EXHIBIT 31.2 ex31-2.htm EX-31 10595
6 EXHIBIT 32.1 ex32-1.htm EX-32 5096
7 EXHIBIT 32.2 ex32-2.htm EX-32 4985
14 logo.jpg GRAPHIC 3239
  Complete submission text file 0001437749-13-014731.txt   8532085

Data Files

Seq Description Document Type Size
8 EXHIBIT 101.INS nby-20130930.xml EX-101.INS 1471686
9 EXHIBIT 101.SCH nby-20130930.xsd EX-101.SCH 51478
10 EXHIBIT 101.CAL nby-20130930_cal.xml EX-101.CAL 35607
11 EXHIBIT 101.DEF nby-20130930_def.xml EX-101.DEF 272181
12 EXHIBIT 101.LAB nby-20130930_lab.xml EX-101.LAB 415708
13 EXHIBIT 101.PRE nby-20130930_pre.xml EX-101.PRE 275720
Mailing Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608
Business Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: CA | Fiscal Year End: 0120
Type: 10-Q | Act: 34 | File No.: 001-33678 | Film No.: 131217049
SIC: 2834 Pharmaceutical Preparations